Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion

Interactive Cardiovascular and Thoracic Surgery

Volumn 5, Issue 5, 2006, Pages 531-535

  Fischer, Uwe M ^a   Antonyan, Albert ^a   Bloch, Wilhelm ^b   Mehlhorn, Uwe ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Antioxidants; Cardioplegic arrest; Cardiopulmonary bypass; Ischemia reperfusion; Nuclear factor kappa B; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACEBO;

APOPTOSIS; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; IMMUNOCYTOCHEMISTRY; ISCHEMIC PRECONDITIONING; OPERATION DURATION; PRIORITY JOURNAL;

EID: 33749401119     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2006.130765     Document Type: Article

References (15)

1. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
2. Fischer UM, Cox CS Jr, Allen SJ, Stewart RH, Mehlhorn U, Laine GA. The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. J Thorac Cardiovasc Surg 2003;126:1483-1488.
3. Fischer UM, Tossios P, Huebner A, Geissler HJ, Bloch W, Mehlhorn U. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2004;128:103-108.
4. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-314.
5. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol 1999;276:H543-H552.
6. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 2001;71:226-232.
7. Gumina RJ, Newman PJ, Kenny D, Warltier DC, Gross GJ. The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury. Basic Res Cardiol 1997;92:201-213.
8. Maulik N, Sato M, Price BD, Das DK. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998;429:365-369.
9. Flanagan RJ, Meredith TJ. Use of N-acetylcysteine in clinical toxicology. Am J Med 1991;91:131S-139S.
10. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984;73:1772-1784.
11. Andersen LW, Thiis J, Kharazmi A, Rygg I. The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 1995;10:21-26.
12. Chandrasekar B, Freeman GL. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett 1997;401:30-34.
13. Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? Faseb J 1999;13:1137-1143.
14. Valen G. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Res Cardiol 2004;99:1-7.
15. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997;3:894-899.